Improved gelatinase A selectivity by novel zinc binding groups containing galardin derivatives

被引：65

作者：

Augé, F

Hornebeck, W

Decarme, M

Laronze, JY

机构：

[1] Univ Reims, Fac Pharm, IFR Biomol 53, UMR 6013, F-51096 Reims, France

[2] Univ Reims, Fac Med, IFR Biomol 53, CNRS,FRE 2534, F-51096 Reims, France

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2003年 / 13卷 / 10期

关键词：

D O I：

10.1016/S0960-894X(03)00214-2

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

The synthesis of several analogues of galardin, a MMP inhibitor, are presented with their in vitro inhibitory activity against MMP-1 and MMP-2. These compounds contain a distinct Zinc Binding Group (ZBG). Those having a 2-acylated-heterocycle as well as a 2-arylamide function do not exhibit a good inhibition/selectivity against the enzymes tested. On the contrary, those that are based on a hydrazide scaffold present potent selectivity for MMP-2 versus MMP-1. (C) 2003 Elsevier Science Ltd. All rights reserved.

引用

收藏

页码：1783 / 1786

页数：4

相关论文

共 25 条

[1] Molecular recognition of protein-ligand complexes: Applications to drug design [J].

Babine, RE ;

Bender, SL .

CHEMICAL REVIEWS, 1997, 97 (05) :1359-1472

[2] Involvement of fibronectin type II repeats in the efficient inhibition of gelatinases A and B by long-chain unsaturated fatty acids [J].

Berton, A ;

Rigot, V ;

Huet, E ;

Decarme, M ;

Eeckhout, Y ;

Patthy, L ;

Godeau, G ;

Hornebeck, W ;

Bellon, G ;

Emonard, H .

JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (23) :20458-20465

[3]

BITAN G, 1995, TETRAHEDRON, V51, P10513

[4] ARYLACETHYDROXAMIC ACIDS - A NEW CLASS OF POTENT NON-STEROID ANTI-INFLAMMATORY AND ANALGESIC SUBSTANCES [J].

BUUHOI, NP ;

LAMBELIN, G ;

GILLET, C ;

LEPOIVRE, C ;

THIRIAUX, J ;

MEES, G .

NATURE, 1966, 211 (5050) :752-&

[5] Inhibition of gelatinase A by oleic acid [J].

Emonard, H ;

Marcq, V ;

Mirand, C ;

Hornebeck, W .

INHIBITION OF MATRIX METALLOPROTEINASES: THERAPEUTIC APPLICATIONS, 1999, 878 :647-649

[6]

Galardy Richard E., 1993, Drugs of the Future, V18, P1109

[7] Preclinical development of metalloproteasis inhibitors in cancer therapy [J].

Giavazzi, R ;

Taraboletti, G .

CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2001, 37 (01) :53-60

[8] THE STEREOSELECTIVE SYNTHESIS OF 2-ALKYL GAMMA-KETO ACID AND HETEROCYCLIC KETOMETHYLENE PEPTIDE ISOSTERE CORE UNITS USING CHIRAL ALKYLATION BY 2-TRIFLYLOXY ESTERS [J].

HOFFMAN, RV ;

KIM, HO .

JOURNAL OF ORGANIC CHEMISTRY, 1995, 60 (16) :5107-5113

[9]

HOMEYER AH, 1953, Patent No. 2630437

[10] Matrix-directed regulation of pericellular proteolysis and tumor progression [J].

Hornebeck, W ;

Emonard, H ;

Monboisse, JC ;

Bellon, G .

SEMINARS IN CANCER BIOLOGY, 2002, 12 (03) :231-241